Mon, December 14, 2020
Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020
Tue, December 8, 2020
Mon, December 7, 2020
Fri, December 4, 2020
Thu, December 3, 2020
Wed, December 2, 2020
Tue, December 1, 2020
Mon, November 30, 2020
Sun, November 29, 2020

Andrew Fein Maintained (BCRX) at Strong Buy with Increased Target to $14 on, Dec 7th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-14-on-dec-7th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy with Increased Target from $13 to $14 on, Dec 7th, 2020.

Andrew has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Liisa Bayko of "Evercore ISI Group" Initiated at Buy and Held Target at $12 on, Tuesday, November 24th, 2020

Publication Contributing Sources